News

Healio12h
Botulinum toxin A formulations offer varying outcomes for frown lines
Certain botulinum toxin type A formulations may offer a faster onset of efficacy, whereas others maintain results for a ...
Reuters1y
Botox rival Revance loses bid to dismiss Allergan trade secrets lawsuit
Revance also separately is developing medication that is biologically similar to Allergan’s Botox. Attorneys for Revance and a representative for the company did not immediately respond to ...
Yahoo3y
Botox maker Allergan draws bid from Valeant
NEW YORK (AP) -- Valeant Pharmaceuticals is teaming up with activist investor Bill Ackman in a bid for Botox maker Allergan that could be worth about $40 billion. Valeant said Monday that it ...
Business Insider3y
Botox has surged in the pandemic. Here's how it's using targeted marketing to keep customers hooked.
Botox sales have been skyrocketing during the pandemic. Allergan, the parent company of Botox, is trying to capitalize on the demand through its marketing. It has set up an internal agency ...
Business Insider4y
Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign
IRVINE, Calif., June 8, 2021 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is changing the way BOTOX ® Cosmetic, the #1 selling neurotoxin treatment 1, is connecting with ...
Business Insider5y
Allergan® Announces First Annual National BOTOX® Cosmetic (onabotulinumtoxinA) Day
DUBLIN, Nov. 18, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), the maker of BOTOX ® Cosmetic, has announced the first-ever National BOTOX ® Cosmetic Day kicking off on November 20. The ...
WFMZ-TV5y
Allergan® Announces First Annual National BOTOX® Cosmetic (onabotulinumtoxinA) Day
Jenny Mollen helps kick off National BOTOX® Cosmetic Day. DUBLIN, Nov. 18, 2019 /PRNewswire/ -- Allergan plc (NYSE: AGN), the maker of BOTOX ® Cosmetic, has announced the first-ever National ...
FiercePharma5y
Whoops! Allergan's bid to shield Botox manufacturing secrets from competitors backfires
Allergan has been more than willing to do whatever necessary to protect its secret process for making blockbuster Botox. After filing a trade theft investigation against a competitor, the ...
New York Post5y
AbbVie to buy Botox maker Allergan in $63 billion deal
Drugmaker AbbVie said Tuesday it would buy Botox maker Allergan for about $63 billion, grabbing control of by far the biggest name in medical aesthetics to help reduce its reliance on blockbuster ...
The New York Times5y
Botox Maker Allergan Is Sold to AbbVie in $63 Billion Deal
The AbbVie deal for Allergan, the maker of Botox, is the second-biggest takeover in the pharmaceutical industry announced this year.Credit...Allergan The drugmaker AbbVie said on Tuesday that it ...
USA Today5y
Humira maker AbbVie to acquire Botox maker Allergan for $63 billion
It was AbbVie. Humira maker AbbVie is set to acquire Botox maker Allergan in another move toward consolidation for the pharmaceutical industry. The deal calls for North Chicago, Illinois-based ...